CLA is often marketed like a “fat burner.” That is too simplistic. Here is what 1,000 mg actually means, what Health Canada allows, what human research shows, and where expectations should stay modest.

If you searched “what is CLA 1000” or “what does CLA 1000 do,” the most useful answer starts with a distinction that supplement marketing often blurs: fat mass is not the same thing as body weight. A product can have a small effect on body composition without producing a dramatic change on the scale. That difference matters when interpreting both Health Canada wording and clinical research.

What Exactly Is CLA 1000?

CLA, or conjugated linoleic acid, refers to a group of fatty-acid isomers related to linoleic acid. “CLA 1000” is not a potency score or a promise of effectiveness. For Biogénique, it is a dose statement: one softgel contains 1,000 mg of CLA. The reviewed label lists 90 softgels and an adult dose of one softgel four times per day, for a total labelled daily amount of 4 g of CLA.

That 4 g/day amount sits inside Health Canada’s current ingredient-monograph range of 3–5 g/day for adults 18 years and older. The monograph also notes that taking CLA with food is optional and advises consulting a healthcare professional for use beyond six months.

What Does CLA 1000 Actually Do?

The strongest way to answer this is to separate the licensed product claim from broader marketing language. The Biogénique label says CLA may help support a modest reduction in fat mass when it is used with a program that reduces dietary calorie intake and increases physical activity. Health Canada’s January 2025 CLA monograph uses similarly cautious language for both fat mass and body composition.

Three words do most of the work here: modest, calories and activity. The claim does not mean CLA independently “melts fat,” raises metabolic rate in a guaranteed way, suppresses appetite, or replaces nutrition and exercise. It also does not promise a specific number of kilograms lost.

What Does the Human Research Show?

The evidence is more restrained than many ads suggest. A 2024 systematic review and dose-response meta-analysis pooled 70 randomized controlled trials with 4,159 adults. Across all studies, CLA was associated with average reductions of about 0.35 kg in body mass, 0.44 kg in fat mass, 0.62 cm in waist circumference and 0.77 percentage points in body-fat percentage, while fat-free mass increased by about 0.27 kg.

Those numbers are statistically measurable, but small. More importantly, the review’s high-quality subgroup did not show a significant reduction in fat mass or body-fat percentage. The authors concluded that CLA may produce small improvements in some body-composition measures, while cautioning that its weight-loss effect may not reach clinical importance.

A separate 2023 systematic review examining CLA combined with exercise also found a reduction in body fat compared with exercise alone, but no meaningful body-weight benefit and no improvement in exercise performance or lipid profile. That pattern reinforces the practical message: CLA may have a small body-composition effect in some settings, but it should not be sold as a dramatic weight-loss or performance supplement.

Evidence boundary: These studies evaluate CLA as an ingredient across different products, populations, doses and durations. They are external scientific evidence—not proof that the Biogénique product will reproduce every reported result.

How Much CLA Is Used?

Health Canada’s current CLA monograph lists 3–5 g/day for adults. Biogénique CLA 1000 supplies 1 g per softgel, and the reviewed label directs adults to take one softgel four times per day, totaling 4 g/day. The fact that research doses vary is not a reason to take more than the product label recommends.

If your goal is weight loss, the Biogénique label specifically tells you to consult a healthcare practitioner before use. Health Canada also advises asking a healthcare professional about use beyond six months. Those are not decorative warnings; they are part of how the ingredient is intended to be used responsibly.

Who Should Not Take CLA?

The reviewed Biogénique label states that the product should not be used by people with cardiovascular disease, diabetes, metabolic syndrome or insulin resistance. It also directs people who are obese, who have cardiovascular risk factors, whose goal is weight loss, or who are pregnant or breastfeeding to consult a healthcare practitioner before use. Gastrointestinal upset can occur.

There is one regulatory nuance worth knowing: Health Canada’s January 2025 ingredient monograph is more conservative on pregnancy and lists pregnancy as a contraindication, while advising consultation before use during breastfeeding. That is ingredient-level guidance rather than a statement that Biogénique’s individual licence has changed. Practically, if you are pregnant, do not self-start CLA; confirm current product guidance with a healthcare professional.

Biogénique CLA 1000: What the Label Actually Says

Because the current label lists gelatin, this softgel should not be described as vegan. The product label—not older marketing copy—controls ingredient disclosure for this article.

Quality & COA: What We Can Verify

Biogénique’s Quality Control page currently lists CLA lot PK240823. The stored Certificate of Analysis identifies that lot as manufactured in August 2024 with an expiry of July 2026. The tested lot met the listed specifications. Because that expiry has now passed, these figures document that specific historical batch; they should not be presented as proof of the currently shipping lot.

A COA is batch-specific. The useful statement is “the tested lot met the listed specifications”—not “zero heavy metals,” and not a blanket guarantee about future batches. Before publication, Biogénique should replace the public CLA COA reference with the current shipping lot if a newer batch is available.

Is CLA 1000 Worth Considering?

CLA may be a reasonable adjunct for an adult who already has the two fundamentals required by the licensed claim: a reduced-calorie eating plan and increased physical activity. The value proposition becomes weak if the expectation is rapid weight loss, appetite suppression, a stimulant effect or a large change on the scale.

1. Start with the goal. If the goal is weight loss, the label says to consult a healthcare practitioner before use.

2. Check contraindications first. CLA is not appropriate for everyone, especially people with cardiovascular disease, diabetes, metabolic syndrome or insulin resistance.

3. Judge the expected effect correctly. “Modest” is the right word; the best current meta-analysis does not support dramatic claims.

4. Use the labelled dose. More is not automatically better, and prolonged use beyond six months warrants professional guidance under the current Health Canada monograph.

5. Check the lot evidence. A current COA should match the lot you are actually buying when possible.

FAQs

Is CLA 1000 a fat burner?

Not in the usual stimulant-style sense. The licensed claim is narrower: CLA may help support a modest reduction in fat mass when paired with reduced calorie intake and increased physical activity. Calling it a stand-alone “fat burner” overstates what the evidence and label support.

Does CLA 1000 make you lose weight?

It does not guarantee weight loss. The 2024 meta-analysis found only small average changes in body mass and body composition, and high-quality studies did not show a significant fat-mass or body-fat-percentage reduction. Diet, activity, adherence and individual response remain much larger variables.

How many Biogénique CLA 1000 softgels should adults take?

The reviewed Biogénique label directs adults to take one 1,000 mg softgel four times per day, for 4 g/day. Follow the current product label rather than copying a dose from a research paper or another brand.

How long can you take CLA?

Health Canada’s current CLA ingredient monograph advises asking a healthcare professional about use beyond six months. Your individual situation and the current product label should guide use.

Does Biogénique CLA 1000 contain gelatin?

Yes. The label reviewed for this article lists gelatin among the non-medicinal ingredients. That means the softgel should not be presented as vegan.

Can I take CLA if I have diabetes?

The reviewed Biogénique label lists diabetes, metabolic syndrome, insulin resistance and cardiovascular disease as contraindications. Do not use the product in those situations unless current licensed guidance changes and your healthcare professional specifically advises otherwise.

Bottom Line

CLA 1000 is straightforward: each Biogénique softgel contains 1,000 mg of conjugated linoleic acid, and the labelled daily dose totals 4 g. What is not straightforward is the marketing around it. Health Canada and the best current human evidence both point in the same direction: any body-composition effect should be expected to be modest, and it belongs beside reduced calories and increased activity—not in place of them. For the right adult, CLA can be considered as an adjunct. For anyone expecting a shortcut, the evidence does not support that promise.

Related Biogénique Resources

• Biogénique CLA 1000 product page

• Biogénique Quality Control / COA lookup

• VitaQuiz™ / Find My Formula

• CoreActives™ Weight Management

Evidence & Compliance Note

Biogénique licensed claim: the reviewed product label states that CLA may help support a modest reduction in fat mass when used with reduced dietary calories and increased physical activity. Health Canada ingredient-level guidance: the January 10, 2025 CLA monograph includes body-composition/fat-mass wording, an adult dose range of 3–5 g/day, duration and risk information. External scientific research: the meta-analyses discussed above evaluate CLA across multiple products and study designs. Their findings are educational evidence and are not presented as authorized Biogénique product claims.

References

1. Health Canada. Conjugated Linoleic Acid natural health product monograph. January 10, 2025. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_conjugated-linoleic-acid_english.pdf

2. Health Canada Natural Health Products Ingredients Database. Conjugated linoleic acid ingredient record. https://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq?id=1538&wbdisable=true

3. Asbaghi O, et al. The effects of conjugated linoleic acid supplementation on anthropometrics and body composition indices in adults: a systematic review and dose-response meta-analysis. Br J Nutr. 2024;131(3):406-428. PMID: 37671495. https://pubmed.ncbi.nlm.nih.gov/37671495/

4. Liang C-W, et al. Effects of conjugated linoleic acid and exercise on body composition and obesity: a systematic review and meta-analysis. Nutr Rev. 2023;81(4):397-415. PMID: 36048508. https://pubmed.ncbi.nlm.nih.gov/36048508/

5. Biogénique. CLA 1000 product page. https://www.biogenique.com/products/cla-1000

6. Biogénique. Quality Control / Certificate of Analysis lookup. https://www.biogenique.com/pages/quality-control

Internal product verification used for this draft: Biogénique CLA 1000 label (NPN 80070240; lot PK240823), Biogénique CLA COA for lot PK240823, and current Biogénique product/quality pages. Product label takes priority over older marketing files when details conflict.

Disclaimer

This article is for general educational purposes and is not medical advice. Natural health products can have contraindications and may not be appropriate for everyone. Follow the current product label and consult a qualified healthcare professional when appropriate, especially if your goal is weight loss, you are pregnant or breastfeeding, you have cardiovascular risk factors, or you have a medical condition.